20
Apicore Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PERPHENAZINE USP, with a corresponding US DMF Number 24646.
Remarkably, this DMF maintains an Active status since its submission on November 28, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 27, 2013, and payment made on November 28, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II